Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123158152 | 12315815 | 2 | F | 201306 | 20160801 | 20160428 | 20160808 | EXP | US-DSJP-DSU-2016-114701 | DAIICHI | 0.00 | Y | 0.00000 | 20160808 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123158152 | 12315815 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 20 MG, QD | Y | 21286 | 20 | MG | TABLET | QD | |||||
| 123158152 | 12315815 | 2 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Oral | 2 MG, QD | 0 | 2 | MG | QD | |||||||
| 123158152 | 12315815 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, BID | 0 | 1000 | MG | BID | |||||||
| 123158152 | 12315815 | 4 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Oral | 10 MG, EVERY 8 HOURS AS NEEDED | 0 | 10 | MG | ||||||||
| 123158152 | 12315815 | 5 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 123158152 | 12315815 | 6 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 123158152 | 12315815 | 7 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123158152 | 12315815 | 1 | Hypertension |
| 123158152 | 12315815 | 2 | Product used for unknown indication |
| 123158152 | 12315815 | 3 | Product used for unknown indication |
| 123158152 | 12315815 | 4 | Product used for unknown indication |
| 123158152 | 12315815 | 5 | Product used for unknown indication |
| 123158152 | 12315815 | 6 | Product used for unknown indication |
| 123158152 | 12315815 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123158152 | 12315815 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123158152 | 12315815 | Anxiety | |
| 123158152 | 12315815 | Constipation | |
| 123158152 | 12315815 | Dizziness | |
| 123158152 | 12315815 | Haemorrhoids | |
| 123158152 | 12315815 | Malabsorption | |
| 123158152 | 12315815 | Rectal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123158152 | 12315815 | 1 | 201304 | 201410 | 0 |